COLONOSCOPY BOWEL PREPARATION DRUGS MARKET ANALYSIS

Regional Analysis

Global Colonoscopy Bowel Preparation Drugs Market- Regional Analysis

The North America colonoscopy bowel preparation drugs market is expected to experience significant growth in the coming years. Factors such as the increasing incidence of colorectal cancer, rising awareness about preventive healthcare, and advancements in medical technology are driving the demand for colonoscopy procedures and, consequently, the need for effective bowel preparation drugs.

For instance, according to the Global Cancer Statistics (GLOBOCAN) published in January 2020, in the U.S., around 147,950 new cases of large bowel cancer are diagnosed annually, of which around 104,610 cases are colon cancer and the remaining are colorectal cancer. According to the same source, around 53,200 Americans die every year due to colorectal cancer, which accounts for around 8% of all cancer deaths occurring, globally.

North America has well-established healthcare systems with favorable reimbursement policies for colonoscopy procedures. These policies encourage individuals to undergo screenings, which, in turn, boosts the demand for bowel preparation drugs.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa